346 related articles for article (PubMed ID: 17251024)
1. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
[TBL] [Abstract][Full Text] [Related]
2. Localization of the alpha-chemokine SDF-1 and its receptor CXCR4 in idiopathic inflammatory myopathies.
De Paepe B; Schröder JM; Martin JJ; Racz GZ; De Bleecker JL
Neuromuscul Disord; 2004 Apr; 14(4):265-73. PubMed ID: 15019705
[TBL] [Abstract][Full Text] [Related]
3. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
6. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
7. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
8. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
9. Beta-chemokine receptor expression in idiopathic inflammatory myopathies.
De Paepe B; De Bleecker JL
Muscle Nerve; 2005 May; 31(5):621-7. PubMed ID: 15772970
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.
de Padilla CM; Reed AM
Curr Opin Rheumatol; 2008 Nov; 20(6):669-74. PubMed ID: 18946326
[TBL] [Abstract][Full Text] [Related]
11. Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
Englund P; Wahlström J; Fathi M; Rasmussen E; Grunewald J; Tornling G; Lundberg IE
Arthritis Rheum; 2007 Jan; 56(1):372-83. PubMed ID: 17195241
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.
Paepe BD; Creus KK; Weis J; Bleecker JL
Neuromuscul Disord; 2012 Jan; 22(1):26-33. PubMed ID: 21855341
[TBL] [Abstract][Full Text] [Related]
13. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
14. Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.
De Paepe B; Creus KK; De Bleecker JL
Ann N Y Acad Sci; 2007 Aug; 1109():441-53. PubMed ID: 17785333
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-like factor expression in the idiopathic inflammatory myopathies.
Chowdhury MH; Nagai A; Terashima M; Sheikh A; Murakawa Y; Kobayashi S; Yamaguchi S
Acta Neurol Scand; 2008 Aug; 118(2):106-14. PubMed ID: 18294340
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
Askanas V; Engel WK; Mirabella M
Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
19. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
Grundtman C; Tham E; Ulfgren AK; Lundberg IE
Arthritis Rheum; 2008 Oct; 58(10):3224-38. PubMed ID: 18821695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]